{"id":"https://openalex.org/W2894559996","doi":"https://doi.org/10.3389/fphar.2018.01096","title":"Using Machine Learning to Predict Synergistic Antimalarial Compound Combinations With Novel Structures","display_name":"Using Machine Learning to Predict Synergistic Antimalarial Compound Combinations With Novel Structures","alternate_titles":[],"publication_year":2018,"publication_date":"2018-10-02","ids":{"openalex":"https://openalex.org/W2894559996","doi":"https://doi.org/10.3389/fphar.2018.01096","mag":"2894559996","pmid":"https://pubmed.ncbi.nlm.nih.gov/30333748","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6176478"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2018.01096","doi":"https://doi.org/10.3389/fphar.2018.01096","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2018.01096","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2018.01096/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2894559996"],"child_works_count":3,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2018.01096/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034234814","display_name":"Daniel J. Mason","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Daniel J. Mason","raw_affiliation_strings":["Department of Chemistry, Centre for Molecular Informatics, University of Cambridge, Cambridge, United Kingdom","Healx Ltd., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Centre for Molecular Informatics, University of Cambridge, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I241749"]},{"raw_affiliation_string":"Healx Ltd., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006398697","display_name":"Richard T. Eastman","orcid":"https://orcid.org/0000-0003-3580-380X","observed_orcids":["https://orcid.org/0000-0003-3580-380X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard T. Eastman","raw_affiliation_strings":["Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, United States","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard P. I. Lewis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard P. I. Lewis","raw_affiliation_strings":["Department of Chemistry, Centre for Molecular Informatics, University of Cambridge, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Centre for Molecular Informatics, University of Cambridge, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I241749"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044827236","display_name":"Ian P. Stott","orcid":"https://orcid.org/0000-0002-0673-2451","observed_orcids":["https://orcid.org/0000-0002-0673-2451"]},"institutions":[{"id":"https://openalex.org/I1342131907","display_name":"Unilever (United Kingdom)","ror":"https://ror.org/05n8ah907","country_code":"GB","type":"company","lineage":["https://openalex.org/I1342131907"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ian P. Stott","raw_affiliation_strings":["Unilever Research and Development, Wirral, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unilever Research and Development, Wirral, United Kingdom","institution_ids":["https://openalex.org/I1342131907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069062997","display_name":"Rajarshi Guha","orcid":"https://orcid.org/0000-0001-7403-8819","observed_orcids":["https://orcid.org/0000-0001-7403-8819","https://orcid.org/0009-0004-4069-0111"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rajarshi Guha","raw_affiliation_strings":["Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, United States","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026643759","display_name":"Andreas Bender","orcid":"https://orcid.org/0000-0002-6683-7546","observed_orcids":["https://orcid.org/0000-0002-6683-7546"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Andreas Bender","raw_affiliation_strings":["Department of Chemistry, Centre for Molecular Informatics, University of Cambridge, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Centre for Molecular Informatics, University of Cambridge, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I241749"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5026643759","https://openalex.org/A5069062997"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I241749","https://openalex.org/I4210148682"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":1.6217,"has_fulltext":true,"cited_by_count":45,"citation_normalized_percentile":{"value":0.84651931,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"9","issue":null,"first_page":"1096","last_page":"1096"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11948","display_name":"Machine Learning in Materials Science","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antimalarial-combination-therapy","display_name":"combination antimalarial therapy","score":0.9129999876022339},{"id":"https://openalex.org/keywords/drug-synergy-prediction","display_name":"drug synergy prediction","score":0.8379999995231628},{"id":"https://openalex.org/keywords/plasmodium-falciparum","display_name":"Plasmodium falciparum","score":0.9729999899864197},{"id":"https://openalex.org/keywords/antimalarial-drug-resistance","display_name":"antimalarial drug resistance","score":0.7160000205039978},{"id":"https://openalex.org/keywords/hydroxyzine","display_name":"hydroxyzine","score":0.8259999752044678},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9309999942779541},{"id":"https://openalex.org/keywords/apicidin","display_name":"apicidin","score":0.9700000286102295},{"id":"https://openalex.org/keywords/dihydroergotamine","display_name":"dihydroergotamine","score":0.9729999899864197},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C99726746","wikidata":"https://www.wikidata.org/wiki/Q906396","display_name":"Chemical space","level":3,"score":0.7200173139572144},{"id":"https://openalex.org/C184898388","wikidata":"https://www.wikidata.org/wiki/Q1435712","display_name":"Pairwise comparison","level":2,"score":0.6835482120513916},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.5706292390823364},{"id":"https://openalex.org/C2778371730","wikidata":"https://www.wikidata.org/wiki/Q311383","display_name":"Plasmodium falciparum","level":3,"score":0.5693541765213013},{"id":"https://openalex.org/C51632099","wikidata":"https://www.wikidata.org/wiki/Q3985153","display_name":"Training set","level":2,"score":0.5431392192840576},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4785673916339874},{"id":"https://openalex.org/C2778048844","wikidata":"https://www.wikidata.org/wiki/Q12156","display_name":"Malaria","level":2,"score":0.47646069526672363},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4717999994754791},{"id":"https://openalex.org/C2777199930","wikidata":"https://www.wikidata.org/wiki/Q736270","display_name":"Mefloquine","level":4,"score":0.46256905794143677},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.45272281765937805},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.45157378911972046},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4422123432159424},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32720625400543213},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25992637872695923},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.24004524946212769},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fphar.2018.01096","doi":"https://doi.org/10.3389/fphar.2018.01096","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2018.01096","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2018.01096/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5136332","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6176478","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:30333748","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30333748","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6176478","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6176478/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:d46e12f59c654f68bd45ae12d75cc670","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d46e12f59c654f68bd45ae12d75cc670","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 9 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2018.01096","doi":"https://doi.org/10.3389/fphar.2018.01096","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2018.01096","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2018.01096/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8423037822","display_name":null,"funder_award_id":"MA-2013-00588","funder_id":"https://openalex.org/F4320309585","funder_display_name":"Unilever"}],"funders":[{"id":"https://openalex.org/F4320309585","display_name":"Unilever","ror":"https://ror.org/05n8ah907"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2894559996.pdf","grobid_xml":"https://content.openalex.org/works/W2894559996.grobid-xml"},"referenced_works_count":66,"referenced_works":["https://openalex.org/W784953694","https://openalex.org/W814444663","https://openalex.org/W1435191252","https://openalex.org/W1603093745","https://openalex.org/W1729198678","https://openalex.org/W1869829652","https://openalex.org/W1974700114","https://openalex.org/W1975459288","https://openalex.org/W1975728616","https://openalex.org/W1977453815","https://openalex.org/W1981678399","https://openalex.org/W1982301941","https://openalex.org/W1988341219","https://openalex.org/W2007852671","https://openalex.org/W2007953805","https://openalex.org/W2008731781","https://openalex.org/W2022515140","https://openalex.org/W2036291018","https://openalex.org/W2040183904","https://openalex.org/W2044025814","https://openalex.org/W2049525425","https://openalex.org/W2050081822","https://openalex.org/W2054306510","https://openalex.org/W2055955780","https://openalex.org/W2061949512","https://openalex.org/W2070778360","https://openalex.org/W2071259655","https://openalex.org/W2082992930","https://openalex.org/W2084222138","https://openalex.org/W2086012629","https://openalex.org/W2099160862","https://openalex.org/W2099768941","https://openalex.org/W2101092227","https://openalex.org/W2101234009","https://openalex.org/W2107258194","https://openalex.org/W2114525333","https://openalex.org/W2116566535","https://openalex.org/W2119002393","https://openalex.org/W2121604817","https://openalex.org/W2129662907","https://openalex.org/W2130410032","https://openalex.org/W2146416540","https://openalex.org/W2154480034","https://openalex.org/W2155626151","https://openalex.org/W2159448584","https://openalex.org/W2160568395","https://openalex.org/W2170146596","https://openalex.org/W2177317049","https://openalex.org/W2196714401","https://openalex.org/W2209382794","https://openalex.org/W2217028767","https://openalex.org/W2256455200","https://openalex.org/W2273821489","https://openalex.org/W2286991429","https://openalex.org/W2473645302","https://openalex.org/W2571957366","https://openalex.org/W2605156573","https://openalex.org/W2612467560","https://openalex.org/W2614307272","https://openalex.org/W2749475934","https://openalex.org/W2755621348","https://openalex.org/W2764045916","https://openalex.org/W2790203313","https://openalex.org/W2798178310","https://openalex.org/W2810727101","https://openalex.org/W2951449549"],"related_works":["https://openalex.org/W4390511787","https://openalex.org/W4286632461","https://openalex.org/W6921079658","https://openalex.org/W2798178310","https://openalex.org/W2217028767","https://openalex.org/W4362703557","https://openalex.org/W3196304395","https://openalex.org/W2467762837","https://openalex.org/W4212799760","https://openalex.org/W4399851988"],"abstract_inverted_index":{"is":[0,47,65,155,259,278,340],"the":[1,146,158,233,318,325,337],"most":[2],"lethal":[3],"species":[4],"of":[5,27,31,36,38,49,57,98,105,117,179,197,204,232,246,281,327],"Plasmodium":[6],"to":[7,102,130,188,201,208,219,238,250,323],"cause":[8],"serious":[9],"malaria":[10],"infection":[11],"in":[12,61,110,136,223,243,311,331],"humans,":[13],"and":[14,96,161,267],"with":[15,44,290],"resistance":[16],"developing":[17],"rapidly":[18],"novel":[19,85,166,182,266,328],"treatment":[20],"modalities":[21],"are":[22,125,140],"currently":[23],"being":[24,29],"sought,":[25],"one":[26,45,153],"which":[28,82,111,191],"combinations":[30,37,109,144,178,187,258,272,330],"existing":[32],"compounds.":[33,183],"The":[34,264],"discovery":[35,326],"antimalarial":[39,107,293,334],"drugs":[40],"that":[41,121,229,254],"act":[42],"synergistically":[43],"another":[46],"hence":[48],"great":[50],"importance;":[51],"however":[52],"an":[53,67,202,244],"exhaustive":[54],"experimental":[55,92,224],"screen":[56],"large":[58],"drug":[59,87,108,329],"space":[60],"a":[62,103,137,220,261],"pairwise":[63,230],"manner":[64],"not":[66,260,303],"option.":[68],"In":[69],"this":[70,212,312,315],"study":[71,316],"we":[72,227],"apply":[73],"our":[74,118,171],"machine":[75],"learning":[76],"approach,":[77],"Combination":[78],"Synergy":[79],"Estimation":[80],"(CoSynE),":[81],"can":[83],"predict":[84],"synergistic":[86,122,240,270],"interactions":[88],"using":[89],"only":[90,152],"prior":[91],"combination":[93,139],"screening":[94,231],"data":[95,214],"knowledge":[97],"compound":[99,154,257,271,305],"molecular":[100],"structures,":[101],"dataset":[104],"1,540":[106],"22.2%":[112],"were":[113],"synergistic.":[114],"Cross":[115],"validation":[116],"model":[119,172],"showed":[120],"CoSynE":[123,184,235],"predictions":[124,175],"enriched":[126],"2.74":[127],"\u00d7":[128,150,163,206,248],"compared":[129,207,249],"random":[131,209,251,262],"selection":[132,210],"when":[133,151],"both":[134],"compounds":[135,234,291],"predicted":[138,185,237,269],"known":[141,156],"from":[142,157,211],"other":[143],"among":[145,256],"training":[147,159],"data,":[148,160],"2.36":[149],"1.5":[162],"for":[164,176,195,320],"entirely":[165,181],"combinations.":[167],"We":[168],"prospectively":[169],"validated":[170,194],"by":[173],"making":[174],"185":[177],"23":[180],"20":[186],"be":[189,239,308],"synergistic,":[190],"was":[192],"experimentally":[193],"nine":[196,265],"them":[198],"(45%),":[199],"corresponding":[200],"enrichment":[203,217,245],"1.70":[205],"prospective":[213],"set.":[215],"Such":[216],"corresponds":[218],"41%":[221],"reduction":[222],"effort.":[225],"Interestingly,":[226],"found":[228],"individually":[236],"would":[241],"result":[242],"1.36":[247],"selection,":[252],"indicating":[253],"synergy":[255],"event.":[263],"correctly":[268],"mainly":[273],"(where":[274],"sufficient":[275],"bioactivity":[276],"information":[277],"available)":[279],"consist":[280],"efflux":[282],"or":[283,300],"transporter":[284],"inhibitors":[285],"(such":[286,296],"as":[287,297],"hydroxyzine),":[288],"combined":[289],"exhibiting":[292],"activity":[294],"alone":[295],"sorafenib,":[298],"apicidin,":[299],"dihydroergotamine).":[301],"However,":[302],"all":[304],"synergies":[306],"could":[307],"rationalized":[309],"easily":[310],"way.":[313],"Overall,":[314],"highlights":[317],"potential":[319],"predictive":[321],"modeling":[322],"expedite":[324],"fight":[332],"against":[333],"resistance,":[335],"while":[336],"underlying":[338],"approach":[339],"also":[341],"generally":[342],"applicable.":[343]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2894559996","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2018-10-12T00:00:00"}
